Yan Lu

2.8k total citations
92 papers, 1.9k citations indexed

About

Yan Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yan Lu has authored 92 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 25 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Yan Lu's work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (9 papers) and CAR-T cell therapy research (8 papers). Yan Lu is often cited by papers focused on MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (9 papers) and CAR-T cell therapy research (8 papers). Yan Lu collaborates with scholars based in China, United States and Australia. Yan Lu's co-authors include Mengsen Li, Mingyue Zhu, Junli Guo, Tom Lawson, Suyan Shan, Yong Liu, Wei Li, Bo Lin, Xieju Xie and Yi Chen and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Yan Lu

85 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Lu China 25 999 377 299 289 241 92 1.9k
Don‐Kyu Kim South Korea 26 1.3k 1.3× 193 0.5× 255 0.9× 341 1.2× 440 1.8× 69 2.5k
Xi Yang United States 28 935 0.9× 321 0.9× 181 0.6× 188 0.7× 387 1.6× 94 2.4k
Xin He China 31 1.6k 1.6× 698 1.9× 299 1.0× 337 1.2× 227 0.9× 103 3.1k
Mehryar Habibi Roudkenar Iran 30 1.3k 1.3× 473 1.3× 204 0.7× 293 1.0× 421 1.7× 147 2.9k
Junfei Jin China 32 1.8k 1.8× 565 1.5× 379 1.3× 353 1.2× 285 1.2× 81 2.8k
I‐Ling Lin Taiwan 18 673 0.7× 227 0.6× 170 0.6× 212 0.7× 105 0.4× 56 1.4k
Xiao‐Han Tang China 21 1.1k 1.1× 250 0.7× 321 1.1× 236 0.8× 268 1.1× 93 2.2k
Feng Xue China 28 808 0.8× 290 0.8× 225 0.8× 375 1.3× 225 0.9× 87 2.3k
Shu Li China 24 914 0.9× 254 0.7× 245 0.8× 182 0.6× 177 0.7× 86 1.8k

Countries citing papers authored by Yan Lu

Since Specialization
Citations

This map shows the geographic impact of Yan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Lu more than expected).

Fields of papers citing papers by Yan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Lu. The network helps show where Yan Lu may publish in the future.

Co-authorship network of co-authors of Yan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Lu. A scholar is included among the top collaborators of Yan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Lu. Yan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ni, Ying, et al.. (2025). Upregulation of CD19 by low‐dose chidamide promotes CAR T cells functionality in B-cell non-Hodgkin lymphoma. Discover Oncology. 16(1). 84–84. 1 indexed citations
2.
Wang, Cong, Xiao Zhang, Yan Lu, & Junying Hao. (2024). Multilayer structure design for preparing ultralow wear amorphous carbon films. Tribology International. 196. 109729–109729. 1 indexed citations
3.
4.
Lu, Yan, et al.. (2024). Knowledge, attitudes, and perceptions of influenza vaccine among pregnant women in Minhang District, Shanghai. Human Vaccines & Immunotherapeutics. 20(1). 2368944–2368944. 2 indexed citations
5.
Lu, Yan, Xinyu Wang, Xiao Zhang, et al.. (2023). Tribological behavior of Cu-modified polymer-derived SiBCN ceramics at elevated temperature. Tribology International. 185. 108540–108540. 5 indexed citations
6.
7.
8.
Lu, Yan, et al.. (2023). Gasdermin E mediates pyroptosis in the progression of hepatocellular carcinoma: a double-edged sword. Gastroenterology report. 12. goae102–goae102. 4 indexed citations
9.
Lu, Yan, Ming‐Hua Zheng, & Hua Wang. (2023). Are hepatocytes endocrine cells?. 3(1). 3–3. 1 indexed citations
10.
Chen, Xiaobing, Wei Li, Dong Xu, et al.. (2023). α-Conotoxin recombinant protein ImI-AFP3 efficiently inhibits the growth and migration of lung cancer cells. Protein Expression and Purification. 215. 106405–106405.
11.
Song, Ge, Yan Lu, Zhidan Yu, et al.. (2019). The inhibitory effect of polysaccharide from Rhizopus nigricans on colitis-associated colorectal cancer. Biomedicine & Pharmacotherapy. 112. 108593–108593. 33 indexed citations
12.
Lu, Yan, et al.. (2018). Analysis of cutaneous Merkel cell carcinoma outcomes after different surgical interventions. Journal of the American Academy of Dermatology. 82(6). 1422–1434. 10 indexed citations
13.
Lin, Bo, Wei Li, Dong Xu, et al.. (2017). Purification and characterization of a bioactive alpha-fetoprotein produced by HEK-293 cells. Protein Expression and Purification. 136. 1–6. 5 indexed citations
14.
Zhang, Cheng, Jun‐Xian Wang, Hua Wang, et al.. (2016). Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation. Toxicology and Applied Pharmacology. 314. 39–47. 69 indexed citations
15.
Huang, Guoliang, Dan Liao, Hua Chen, et al.. (2016). The protein level and transcription activity of activating transcription factor 1 is regulated by prolyl isomerase Pin1 in nasopharyngeal carcinoma progression. Cell Death and Disease. 7(12). e2571–e2571. 33 indexed citations
16.
Zhao, Yun, Yan Lu, Xiumei Luo, et al.. (2016). A novel PPARα agonist propane-2-sulfonic acid octadec-9-enyl-amide inhibits inflammation in THP-1 cells. European Journal of Pharmacology. 788. 104–112. 12 indexed citations
17.
Wu, Qiong, Xing Liu, Yafang Liu, et al.. (2013). Inhibition of p38 activity reverses claudin-6 induced cell apoptosis, invasion, and migration. Chinese Medical Journal. 126(18). 3539–3544. 10 indexed citations
18.
19.
Wang, Yian, Zhongqiu Zhang, Yan Lu, et al.. (2008). Enhanced Susceptibility to Chemical Induction of Ovarian Tumors in Mice with a Germ Line p53 Mutation. Molecular Cancer Research. 6(1). 99–109. 8 indexed citations
20.
Lu, Yan. (2004). Immunotherapeutic effects of soluble chicken collagen typeII on collagen typeII induced arthritis in rats. Zhongguo yaolixue yu dulixue zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Don‐Kyu Kim Breakdown of academic impact, for papers by Xi Yang Breakdown of academic impact, for papers by Xin He Breakdown of academic impact, for papers by Mehryar Habibi Roudkenar Breakdown of academic impact, for papers by Junfei Jin Breakdown of academic impact, for papers by I‐Ling Lin Breakdown of academic impact, for papers by Xiao‐Han Tang Breakdown of academic impact, for papers by Feng Xue Breakdown of academic impact, for papers by Shu Li
Rankless by CCL
2026